Heron Therapeutics (HRTX) Convertible Debt (2011 - 2026)
Heron Therapeutics' Convertible Debt came in at $33.93 million for Q2 2026, up 1.8% from the prior quarter.
Powered by 
Analysis
Heron Therapeutics (HRTX) Convertible Debt (2011 - 2026) Analysis & Trends
At the end of FY2025, Heron Therapeutics' Convertible Debt was $32.74 million, down 78.1% from FY2024.
- Convertible Debt carries a four-year compound annual growth rate of -31.5% (FY2021 to FY2025).
- Going back by year, Convertible Debt was $149.7 million in FY2024 (+0.1%), $149.49 million in FY2023 (+0.1%), $149.28 million in FY2022 (+0.1%) and $149.08 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Convertible Debt since Q1 2025.
- Year-over-year, Convertible Debt increased in three of the last six quarters, with an average decline of 39.0%.
- The fastest year-over-year change in Convertible Debt over five years came in Q1 2025 (growth of 0.1%), and the weakest in Q3 2025 (a decline of 78.5%).
- Business Quant data shows HRTX's Convertible Debt at $33.33 million (Q1 2026), $32.74 million (Q4 2025) and $32.18 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Heron Therapeutics | 58.85 Mn | -130.71 Mn | 26.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.93 Mn |
| Mar 31, 2026 | 33.33 Mn |
| Dec 31, 2025 | 32.74 Mn |
| Sep 30, 2025 | 32.18 Mn |
| Mar 31, 2025 | 149.75 Mn |
| Dec 31, 2024 | 149.70 Mn |
| Sep 30, 2024 | 149.65 Mn |
| Jun 30, 2024 | 149.60 Mn |
| Mar 31, 2024 | 149.54 Mn |
| Dec 31, 2023 | 149.49 Mn |
| Sep 30, 2023 | 149.44 Mn |
| Jun 30, 2023 | 149.39 Mn |
| Mar 31, 2023 | 149.34 Mn |
| Dec 31, 2022 | 149.28 Mn |
| Sep 30, 2022 | 149.23 Mn |
| Jun 30, 2022 | 149.18 Mn |
| Mar 31, 2022 | 149.13 Mn |
| Dec 31, 2021 | 149.08 Mn |
| Sep 30, 2021 | 149.03 Mn |
| Jun 30, 2021 | 148.98 Mn |
API Access
Heron Therapeutics Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=HRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "HRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=HRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();